Structure |
Chemical Name |
CAS |
MF |
 |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
 |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
 |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
 |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
 |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
 |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
 |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
 |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
 |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
 |
Isavuconazole Impurity 48 |
|
|
![1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid](/CAS2/GIF/1163685-30-0.gif) |
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1163685-30-0 |
C14H11N3O3 |
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
 |
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
 |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one) |
|
|
![2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid](/CAS/20181212/GIF/CB39996369.gif) |
2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |
|
C27H35N3O3 |
 |
Tafluprost Impurity 19 |
|
|
 |
Rosuvastatin Impurity 162 |
|
|
 |
Rosuvastatin Impurity 151 |
|
|
 |
Rosuvastatin Impurity 148 |
|
|
 |
フロセミドアシルグルクロニド |
72967-59-0 |
C18H19ClN2O11S |
 |
Digoxin Impurity 1 |
|
|
 |
Bimatoprost Impurity 23 |
|
|
 |
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
 |
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
 |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
 |
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
 |
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
 |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
 |
Irbesartan impurity A |
|
C25H28N6O |
![(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine](/CAS/20180713/GIF/223673-35-6.gif) |
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
 |
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
![4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド](/CAS/GIF/1193725-75-5.gif) |
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
 |
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione |
3754-05-0 |
C21H26O6 |
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-43-5.gif) |
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
 |
N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン |
1346601-52-2 |
C23H25N3O4 |
![5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン](/CAS/GIF/951624-49-0.gif) |
5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン |
951624-49-0 |
C13H11FN4O |
 |
ペリンドプリラットラクタムB |
130061-28-8 |
C17H26N2O4 |
 |
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
 |
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
 |
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
 |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
 |
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
 |
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
 |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
 |
Tafluprost Impurity 17 |
|
|
![(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB32735563.gif) |
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
 |
Posaconazole iMpurity 5 |
|
|
 |
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
 |
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
 |
Norepinephrine Tartrate Impurity G |
13062-58-3 |
C22H21NO3 |
 |
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
 |
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
 |
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone |
98414-56-3 |
C7H8N6O |
![2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol](/CAS/20180629/GIF/1354945-69-9.gif) |
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol |
1354945-69-9 |
C17H26N6O4S |
 |
Vonoprazan Impurity E |
|
|
 |
ジサリチルイミド |
1972-71-0 |
C14H11NO4 |
 |
Atomoxetine impurity D |
1643684-02-9 |
C17H21NO |
 |
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
 |
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
 |
Parecoxib Impurity M |
|
|
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-](/CAS/20200119/GIF/1648791-23-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
 |
Linagliptin Impurity O |
|
|
 |
Linagliptin Impurity T |
|
|
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
 |
Etoricoxib Impurity 16 |
|
|
 |
Ibrutinib Impurity 2 |
|
|
 |
Mirabegron Impurity 14 |
|
|
 |
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
 |
Atenolol EP Impurity |
|
C14H22N2O3 |
 |
Cinacalcet Impurity 20 |
|
|
 |
Dapagliflozin Impurity 11 |
|
|
 |
Dasatinib Impurity C |
|
|
 |
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
 |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
 |
6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione |
30222-00-5 |
C9H5Cl2N3O2 |
 |
ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)- |
863329-65-1 |
C24H21FN2O7 |
 |
Celecoxib iMpurity-A |
|
|
 |
EMtricitabine iMpurity A |
|
|
 |
RocuroniuMbroMide iMpurity D |
|
|
 |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
 |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
 |
デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド |
139756-27-7 |
C15H15ClN4O4S |
 |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
 |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
 |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
 |
Irinotecan IMpurity G |
947687-02-7 |
C35H42N4O6 |
 |
ジヒドロキシベンダムスチン |
109882-30-6 |
C16H23N3O4 |
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
 |
Lafutidine IMpuritiy B |
174583-84-7 |
C22H29N3O5S |